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Background/aim: Plastic biliary stents that remain in situ for more than 12 months, called forgotten biliary stents (FBSs), can cause
complications such as cholangitis, stent migration, stent occlusion, and perforation.
Materials and methods: The medical records of patients who underwent ERCP procedures from December 2016 to December 2020
were analysed retrospectively. Data on patient characteristics, indications for ERCP and stenting, stent types, stenting duration,
complications, and causes of FBSs were obtained from the hospital’s database.
Results: A total of 48 cases with FBSs were analysed. The mean age (SD) of the patients was 71.23 years (±12.165), the male-to-female
ratio was 23/25 (0.92), and the mean stenting duration was 27.12 months (range: 12–84 months). The most common indication for
biliary stenting was irretrievable choledochal stones (40/48). Stone formation (79%) and proximal stent migration (26.4%) were the
most frequent complications. The patients in the FBS group were significantly older than those from whom stents were removed in a
timely manner (71.23 vs. 62.43 years, p < 0.001). Endoscopic treatment was possible in all cases; surgery was not required in any case.
The most common cause of FBSs cited by patients was not having been informed about the need for long-term management of their
stents (n = 14, 29.2%)
Conclusion: FBSs are potentially problematic particularly in elderly patients. Communication with the patient to remind them of the
need for stent management is important for preventing FBSs.
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1. Introduction
Endoscopic retrograde cholangiopancreatography (ERCP)
with endoscopic biliary stenting (EBS), using a plastic or
metallic stent, is the standard of care for choledocholithiasis
and several other obstructive biliary diseases. Metallic
stents are typically used in cases with malignant obstruction
of bile ducts, and plastic stents for benign biliary strictures
or irretrievable choledochal stones. Plastic stents are not
intended for permanent use and should be replaced after
3–6 months [1]. Stents retained for more than 12 months
are termed forgotten biliary stents (FBSs), and result
in complications such as stent occlusion, migration,
cholangitis, and perforation [2,3]. Other complications—
such as diarrhoea, haemobilia, and giant stentoliths—are
also encountered, albeit rarely [4–6].
Endoscopists performing ERCP frequently encounter
FBSs. Most information on FBSs is from case reports;
few studies have evaluated FBSs’ complications and
management [7-9]. In this retrospective study, we
evaluated the incidence, complications, and management
of FBSs in patients undergoing ERCP.

2. Materials and methods
The medical records of patients who underwent ERCP
procedures performed in the Gastroenterology Endoscopy
Department of Kocaeli University Medical Faculty
from December 2016 to December 2020 were analysed
retrospectively. Data on patient characteristics, ERCP and
stenting indications, stent types, stenting duration, and
complications were obtained from the hospital database.
Biliary plastic stents inserted for benign diseases, which
remained in situ for more than 12 months, were defined as
FBSs. The causes of FBSs were obtained from the medical
records and by conducting telephone interviews.
Ethical approval for this study was obtained from
the Ethics Committee of Kocaeli University, Faculty of
Medicine (approval number: GOKAEK-2020/21.7).
Statistical analysis was performed using SPSS for
Windows software (ver. 20.0;IBM Corp., Armonk, NY,
USA).The Kolmogorov–Smirnov and Shapiro–Wilk tests
were used to assess the normality of the data. Continuous
variables are presented as means ± standard deviation
or medians (ranges). Categorical variables are shown
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as counts (percentages). Continuous variables were
compared between groups by independent-samples t-test.
Associations between categorical variables were examined
by chi-squared test. In all analyses, a two-sided p-value
<0.05 was indicative of statistical significance.
3. Results
A total of 1460 ERCP procedures were performed in 959
patients between December 2016 and December 2020.The
mean (SD) age of the patients was 61.04 (17.119) years. Of
the patients, 473 were female (49%) and 486 male (51%),
and 487 biliary plastic stents and 87 self-expandable
metallic stents were placed (Table1). Forty-eight biliary
plastic stents remained in situ for more than 12 months
in 44 patients; the mean (SD) age of those patients was
71.23 (12.165) years, and the median stenting duration
was 22.5 (12–84) months (Table 1). The most common
reason for FBSs reported by patients was not having been
informed of the need for long-term stent management
(29.2%). Seven patients had undergone cholecystectomy
after ERCP and believed that their stent had been removed
during the procedure. Six patients were noncompliant,
possibly because they believed that their stent was to
remain in place permanently (Table 1).

Out of 48 plastic biliary stents, 41 had been placed in
our department, and 7 had been placed at other centres.
Thirty-four FBSs (one previous) were encountered during
ERCP, most of which were symptomatic. A database
search identified 14 (3 previous) asymptomatic FBSs;
the patients were contacted by telephone. Because of
restrictions in place as a result of the ongoing coronavirus
disease 2019 (COVID-19) pandemic, those patients could
not be called for ERCP and stent removal. Instead, we
explained the symptoms of FBSs and instructed them to
visit the Endoscopy Department if they experienced any.
The patients in the FBS group were significantly older than
those from whom biliary stents were removed in a timely
manner (71.2 vs. 62.4 years, p < 0.001) (Table 2).
The most common indication for biliary stenting
was irretrievable choledochal stones, followed by benign
biliary strictures and post-cholecystectomy biliary leak.
Stone formation was noted in three of the seven patients
in whom the initial stenting indication was benign biliary
stricture or post-cholecystectomy biliary leak. A stentolith
was seen in one case (Figure 1B) and a giant stone in
another patient (Figure 2A); the latter was managed by
cholangioscopy and laser lithotripsy (Figure 2B). Proximal
migration of stents and stent fracture (Figure 1A) were

Table 1. Demographic and clinical characteristics of study population.
Baseline patient characteristics
Number of patients
Age, mean(SD), years
Gender, male/female n(%)
ERCP procedures, n
Stents inserted, n
Stent type (Benign/malignant condition)
Plastic, n
Self-expandable metallic, n
Characteristics of patients with FBS
Number of patients
Age, mean(SD), years
Gender, male/female
ERCP performed (M/F)
ERCP not performed (M/F)
Duration of stenting, months, median (range)
Causes of FBS
Uninformed patient
Believed the stent had been removed
during cholecystectomy
Expecting a telephone call
Incompatible patient
COVID-19-related
No information available
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959
61.04 (±17.119)
486(51)/473(49)
1460
574
270/217
17/70
44 (4 patients experienced two episodes of FBSs)
71.23 (±12.165)
23/25
34 (17/17)
14 (6/8)
22.5(12–84 months)
n(%)
14(29.2)
7 (14.6)
6(12.5)
6(12.5)
2(4.2)
13(27.1)
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Table 2. Comparison of patients’ages between forgotten and timely removed stents.

Number of patients
Mean age(SD) years

Stent not forgotten

FBS

p-value

155
62.43(16.758)

44
71.23(12.165)

<0.001

Figure 1.A. Fragmented stent in the distal part of the choledochus, 24 months after stent placement. B. Stentolith 20 months after stent
placement.

Figure 2. A. Giant stone 48 months after stent placement. B. Laser lithotripsy of the stone.
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also encountered. Endoscopic treatment was possible
in all cases; surgery was not required in any case. Nonmigrated stents were easily retrieved using a snare or
basket. A new stent was placed in the case of large stones
or a biliary stricture. Of the nine proximally migrated
stents in our series, four were retrieved endoscopically.
We did not consider surgery in the remaining cases
because biliary drainage was maintained by exchanging
the stent. If endoscopic retrieval during follow-up ERCP
was not feasible, cholangioscopy-assisted retrieval
would be considered. The stenting indications, clinical
presentations, FBS-related complications, and applied
endoscopic treatments are given in detail in Table 3.
4. Discussion
Plastic biliary stents are used to maintain bile flow in
patients with benign biliary diseases, such as irretrievable
choledochal stones, benign biliary strictures, or postcholecystectomy biliary leaks. In this study, the most
common indication for biliary stenting was irretrievable
common bile duct stones. The mean duration of stenting
was 27.12 (range: 12–84) months. In cases of irretrievable
choledochal stones, biliary stents may be used as bridge
therapy to maintain bile flow and reduce stone size and,
thus, facilitate later endoscopic removal [10–12]. In such
instances, biliary stents remain in place for 2–6 months
before definitive endoscopic therapy. Plastic biliary stents
may be used for longer periods in elderly patients and
those with contraindications for surgery. Pisello et al.
treated 30 high-risk patients with difficult common bile
duct stones by permanent stenting; the median followup was 38 months. The most frequent late complication
is cholangitis, which is managed by stent substitution
[13]. In long-standing biliary stents, obstruction by
plugs is problematic. Plugs are formed by biliary sludge
accumulation and result in bacterial adhesion microbial
biofilm growth, which promotes cholangitis [14]. Biliary
stents should remain in situ for no more than 3–6 months
to prevent cholangitis [1]. Cholangitis was the most
frequent finding among the patients with symptomatic
FBS in our case series. Even a completely obstructed
stent may not disrupt bile flow because of the existence
of a passage between the choledochus and the stent [8].
Therefore, FBSs can be asymptomatic for long periods.
The patients in our FBS group were older than those
in whom the plastic biliary stents had not been forgotten.
This is because elderly people face physical impairment
and mental and social problems, leading to increased
dependency [15] and hampering access to healthcare
services. Therefore, more caution is required to prevent
FBS when placing stents in elderly patients.
In most cases, FBSs can be retrieved by endoscopic
techniques. However, management of long-term-retained
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Table 3. Stenting indications, clinical presentations, complications
and endoscopic treatment of FBSs.
Parameter

n(%)

Stenting indication
Irretrievable choledochal stones
Benign biliary stricture
Post-cholecystectomy biliary leak

40(83.3)
5(10.4)
3(6.2)

Clinical presentation(ERCP+)
Cholangitis
Jaundice
Biliary pancreatitis
Asymptomatic

22(64.7)
6(17.6)
2(5.8)
4(11.7)

FBS-related complications
Choledocholithiasis
Proximal migration of stent
Fracture of stent
Giant stone
Stentholith

27(79)
9(26.4)
3(8.8)
1(2.9)
1(2.9)

Endoscopic treatment
Stent could not be retrieved, additional stent placed
Stent retrieved by snare or basket
Stent retrieved; new stent placed for large stones
Stent retrieved; new stent placed for biliary stricture

5(14.7)
19(55.8)
9(26.4)
1(2.9)

stents is hampered by complications such as stent
migration and fragmentation, as well as “giant stentolith”
formation. Bacterial colonisation of stents triggers the
release of b‑glucuronidase, which deconjugates bilirubin
glucuronide into calcium bilirubinate crystals. These
crystals aggregate on the stent and form a stone cast,
i.e. a stentolith [16]. Giant stentoliths must be removed
surgically [4,17]. In a prior series, most FBS cases were
managed surgically [9], whereas in another surgery
management was not needed [8]. The study with a high
surgery rate [9] had longer mean and maximum stent
patency times (3.53 [range: 1–14] years) compared with
those in our study (22.6 ± 12[range: 12–84] months) and
that by Sohn (22.6±12.2 [range: 12–58] months) [8]. This
may explain the requirement for surgery, which could
also be attributed to the higher prevalence of stentoliths
[8]. The single stentolith encountered in our case series
was managed endoscopically; therefore, surgery was not
required in this case series.
Most of our patients stated that they were not informed
of the need for biliary stent management. Trainee
physicians involved in ERCP may forget to provide
patients with such information [18]. In our centre, trainee
physicians are in some cases responsible for providing
patients with information on stent management. Six
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patients stated that they were expecting a telephone call
from the hospital. In patients with ureteral stents, electronic
reminders prevented forgotten stents [19,20] and could
be similarly efficacious for biliary stents. In patients with
choledocholithiasis, cholecystectomy is often performed
after ERCP to prevent recurrent choledocholithiasis [21].
Some of our patients believed that their stent had been
removed during cholecystectomy following ERCP and did
not attend their follow-up ERCP appointment. Therefore,
patients should be admitted to the Gastroenterology
Department for stent removal after cholecystectomy.
We have begun to pay more attention to prevent FBS
cases in our unit. The senior physician performing the
ERCP procedure always instructs the patients’ relatives
about subsequent management of an inserted biliary
stent. A subsequent appointment for ERCP is arranged
before discharge, and written details are provided to the

patient and relatives. We emphasize the need for ERCP
referral for patients undergoing cholecystectomy in which
a biliary plastic stent was inserted before the surgery. As
other preventive measure taken by our unit, all ERCP
procedures are reviewed by a fellow at 3-month intervals,
and the patients who do not present for removal of their
stent in time are contacted. We also plan to implement an
electronic reminder service for patients undergoing biliary
stent insertion.
In conclusion, FBSs are potentially problematic and
more common in older patients. Complications of FBS
can be managed by endoscopic techniques. FBSs can be
prevented by effective communication with the patient;
reminder services could also be an option.
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